Infliximab-related vasculitis in patients affected by ulcerative colitis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 51, Issue 2, 2010, Pages 226-228

  Pastore, Serena ^a   Londero, Margherita ^a   Gortani, Giulia ^a   Abate, Maria Valentina ^a   Marchetti, Federico ^a   Di Leo, Grazia ^a   Ventura, Alessandro ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CIPROFLOXACIN; CYCLOSPORIN; INFLIXIMAB; MESALAZINE; METHOTREXATE; METRONIDAZOLE; STEROID; THALIDOMIDE;

ACUTE HEPATITIS; ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CHILD; COLON CROHN DISEASE; COLONOSCOPY; CROHN DISEASE; DIARRHEA; DRUG WITHDRAWAL; FEMALE; FEVER; HEMORRHAGIC GASTRITIS; HOSPITAL ADMISSION; HUMAN; LARYNGOTRACHEOBRONCHITIS; MALE; PNEUMOMEDIASTINUM; PRIORITY JOURNAL; PYODERMA; RASH; RECURRENT DISEASE; REMISSION; SCHOOL CHILD; SKIN MANIFESTATION; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT FAILURE; TREATMENT WITHDRAWAL; ULCERATIVE COLITIS; VASCULITIS; VOMITING;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CHILD; COLITIS, ULCERATIVE; FEMALE; HUMANS; MALE; VASCULITIS;

EID: 77955229838     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181e5e198     Document Type: Article

References (11)

1. Han PD, Cohen RD. Managing immunogenic resposes to infliximab: treatment implications for patients with Crohn's disease. Drugs 2004;64:1767-1777
2. De Bandt M, Sibilia J, Le Loet X, et al. Systemic lupus erythematosus induced by anti-tumor necrosis factor alpha therapy: a French national survey. Arthritis Res Ther 2005;7:R545-51.
3. Chandha T, Hernandez JE. Infliximab-related lupus and associated valvulitis: a case report and review of the literature. Arthritis Rheum 2006;55:163-166
4. Ramos-Casals M, Brito-Zeron P, Munoz S, et al. Autoimmune diseases induced by TNF-targeted therapies. Medicine 2007;86:242-251
5. Lazzerini M, Martelossi S, Maschio M, et al. Thalidomide for treating refractory Crohn's disease and ulcerative colitis in children: randomized controlled trial (preliminary results). J Crohns Colitis 2009;3:8.
6. Markowitz J. Current treatment of inflammatory bowel disease in children. Dig Liv Dis 2008;40:16-21.
7. Borrelli O, Bascietto C, Viola F, et al. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease. Dig Liver Dis 2004;36:342-347
8. Keating GM, Perry CM. Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis. BioDrugs 2002;16:111-148
9. Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005; 353:2462-2476 (Pubitemid 41770166)
10. Lawson MM, Thomas AG, Akobeng AK. Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2006;3:CD005112.
11. Bermejo F, López San Román A, Algaba A, et al. Efficacy of premedication with intravenous corticosteroids and antihistaminics in preventing infusion reactions to infliximab. Gastroenterol Hepatol 2008;31:629-632